Article Details

Sangamo Therapeutics (NASDAQ:SGMO) Cut to "Sell" at Zacks Investment Research | MarketBeat

Retrieved on: 2021-10-09 08:15:00

Tags for this article:

Click the tags to see associated articles and topics

Sangamo Therapeutics (NASDAQ:SGMO) Cut to "Sell" at Zacks Investment Research | MarketBeat. View article details on HISWAI: https://www.marketbeat.com/instant-alerts/nasdaq-sgmo-a-buy-or-sell-right-now-2021-10/

Excerpt

Acadian Asset Management LLC now owns 9,925 shares of the biopharmaceutical company's stock valued at $124,000 after purchasing an additional 3,240 shares ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up